Canaccord raised the firm’s price target on HealthStream (HSTM) to $29 from $28 and keeps a Hold rating on the shares. The firm said they posted another steady quarter and noted the the sales pipeline is strong across core product areas in CredentialStream, ShiftWizard, and API related products. Adoption of APIs and the Developer Portal has continued to gain traction, with the number of organizations and third-party developers accessing the portal roughly doubling in the last twelve months.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HSTM:
- HealthStream price target raised to $34 from $32 at Barclays
- Closing Bell Movers: Medpace down 11% after cutting FY24 revenue guide
- HealthStream Reports Strong Q3 2024 Financial Results
- HealthStream reports Q3 EPS 19c, consensus 12c
- HealthStream cuts FY24 revenue view to $292M-$296M from $290M-$292M